Role of Sentinel Lymph Node Biopsy in Ductal Carcinoma-in-situ Treated by Mastectomy Jensen C. C. TanDavid R. McCreadyWey L. Leong OriginalPaper 14 November 2006 Pages: 638 - 645
Is Routine Sentinel Lymph Node Biopsy Indicated in Women Undergoing Contralateral Prophylactic Mastectomy? Magee-Womens Hospital Experience Atilla SoranJeffrey FalkRonald Johnson OriginalPaper 23 November 2006 Pages: 646 - 651
Selective Application of Axillary Node Dissection in Elderly Women with Early Breast Cancer Dalal AzizSandra GardnerClaire M. B. Holloway OriginalPaper 06 December 2006 Pages: 652 - 659
Feasibility of Breast Preserving Therapy with Single Fraction In Situ Radiotherapy Delivered Intraoperatively David W. OllilaNancy Klauber-DeMoreCarolyn I. Sartor OriginalPaper 08 November 2006 Pages: 660 - 669
Predicting Patients at Low Probability of Requiring Postmastectomy Radiation Therapy Anees B. ChagparCharles R. ScogginsKelly M. McMasters OriginalPaper 10 November 2006 Pages: 670 - 677
Personality Predicts Quality of Life Six Months after the Diagnosis and Treatment of Breast Disease A. F. W. van der SteegJ. De VriesJ. A. Roukema OriginalPaper 05 December 2006 Pages: 678 - 685
Quality of Life After Bilateral Prophylactic Mastectomy Ann M. GeigerLarissa NekhlyudovKaren M. Emmons OriginalPaper 11 November 2006 Pages: 686 - 694
Type and Duration of Exogenous Hormone Use Affects Breast Cancer Histology Anjali S. KumarElizabeth CuretonE. Shelley Hwang OriginalPaper 14 November 2006 Pages: 695 - 703
Predictive Value of Breast Lesions of “Uncertain Malignant Potential” and “Suspicious for Malignancy” Determined by Needle Core Biopsy Mary F. DillonEnda W. McDermottCecily M. Quinn OriginalPaper 07 December 2006 Pages: 704 - 711
Surgical Treatment of Solitary Thyroid Nodules Via Fine-Needle Aspiration Biopsy and Frozen-Section Analysis Tzu-Chieh ChaoJen-Der LinMiin-Fu Chen OriginalPaper 06 December 2006 Pages: 712 - 718
Anaplastic Thyroid Carcinoma: Expression Profile of Targets for Therapy Offers New Insights for Disease Treatment Sam M. WisemanHamid MasoudiBlake Gilks OriginalPaper 10 November 2006 Pages: 719 - 729
Prognostic Factors in Papillary and Follicular Thyroid Carcinoma: Their Implications for Cancer Staging Brian Hung-Hin LangChung-Yau LoKoon-Yat Wan OriginalPaper 11 November 2006 Pages: 730 - 738
Radioguided Parathyroidectomy in Patients with Familial Hyperparathyroidism Alysandra LalJesus BiancoHerbert Chen OriginalPaper 23 November 2006 Pages: 739 - 743
Local/Cervical Block Anesthesia versus General Anesthesia for Minimally Invasive Parathyroidectomy: What are the Advantages? Michael J. BlackAnn E. RuscherHerbert Chen OriginalPaper 23 November 2006 Pages: 744 - 749
Quality of Life after Pancreatectomy C. D. JohnsonF. HowseS. L. George Letter ot the Editor 06 December 2006 Pages: 750 - 751
COX-2 Expression in Hepatocellular Carcinoma is an Initiation Event; While EGF Receptor Expression with Downstream Pathway Activation is a Prognostic Predictor of Survival Jason FosterJennifer BlackJohn F. Gibbs OriginalPaper 05 December 2006 Pages: 752 - 758
Lack of Evidence for Increased Operative Morbidity After Hepatectomy with Perioperative Use of Bevacizumab: A Matched Case-Control Study Michael D’AngelicaPeter KornpratLeonard B Saltz OriginalPaper 11 November 2006 Pages: 759 - 765
Asymptomatic Colorectal Cancer with Un-Resectable Liver Metastases: Immediate Colorectal Resection or Up-Front Systemic Chemotherapy? Andrea MuratoreDaria ZorziLorenzo Capussotti OriginalPaper 14 November 2006 Pages: 766 - 770
The Role of FDG-PET in the Selection of Patients with Colorectal Liver Metastases B. WieringP. F. M. KrabbeT. J. M. Ruers OriginalPaper 05 November 2006 Pages: 771 - 779
Biomarkers Predict Outcomes Following Cytoreductive Surgery for Hepatic Metastases from Functional Carcinoid Tumors Eric H. JensenLarry KvolsDavid Shibata OriginalPaper 05 December 2006 Pages: 780 - 785
Clinicopathological Features and Prognosis in Resectable Synchronous and Metachronous Colorectal Liver Metastasis Ming-Shian TsaiYen-Hao SuPo-Huang Lee OriginalPaper 14 November 2006 Pages: 786 - 794
Synergistic Antitumor Effects of Histamine Plus Melphalan in Isolated Hepatic Perfusion for Liver Metastases Flavia BrunsteinAlexander M. M. EggermontTimo L. M. ten Hagen OriginalPaper 10 November 2006 Pages: 795 - 801
Correlation Between Melphalan Pharmacokinetics and Hepatic Toxicity Following Hyperthermic Isolated Liver Perfusion for Unresectable Metastatic Disease Simone MocellinPierluigi PilatiMario Lise OriginalPaper 14 November 2006 Pages: 802 - 809
Detection of Disseminated Tumor Cells in Liver Biopsies of Colorectal Cancer Patients Is not Associated with a Worse Prognosis Moritz KochPeter KienleJürgen Weitz OriginalPaper 11 November 2006 Pages: 810 - 817
Comparison of Multiphase CT, FDG-PET and Intra-Operative Ultrasound in Patients with Colorectal Liver Metastases Selected for Surgery B. WieringT. J. M. RuersW. J. G. Oyen OriginalPaper 29 November 2006 Pages: 818 - 826
Incidence Pattern and Survival for Gallbladder Cancer Over Three Decades—An Analysis of 10301 Patients R. P. KiranN. PokalaS. J. Dudrick OriginalPaper 16 November 2006 Pages: 827 - 832
Gallbladder Cancer: Defining the Indications for Primary Radical Resection and Radical Re-resection Jason M. FosterHisakazu HoshiBoris Kuvshinoff OriginalPaper 11 November 2006 Pages: 833 - 840
Amelioration of Operation-Induced Suppression of Marginating Pulmonary NK Activity using Poly IC: A Potential Approach to Reduce Postoperative Metastasis Guy ShakharNaphtali AbudarhamShamgar Ben-Eliyahu OriginalPaper 08 November 2006 Pages: 841 - 852
Neoplastic Mesorectal Microfoci (MMF) following Neoadjuvant Chemoradiotherapy: Clinical and Prognostic Implications Carlo RattoRiccardo RicciGiovanni B. Doglietto OriginalPaper 11 November 2006 Pages: 853 - 861
Cancer Cells Cause Vascular Endothelial Cell (vEC) Retraction via 12(S)HETE Secretion; The Possible Role of Cancer Cell Derived Microparticle Keiji UchideMasato SakonMorito Monden OriginalPaper 12 November 2006 Pages: 862 - 868
A phase-I Trial Using a Universal GM-CSF-producing and CD40L-expressing Bystander Cell Line (GM.CD40L) in the Formulation of Autologous Tumor Cell-based Vaccines for Cancer Patients with Stage IV disease Sophie DessureaultDavid NoyesScott J. Antonia OriginalPaper 14 November 2006 Pages: 869 - 884
Opa Interacting Protein 5 (OIP5) Is a Novel Cancer-testis Specific Gene in Gastric Cancer Yoshito NakamuraFumiaki TanakaMasaki Mori OriginalPaper 07 December 2006 Pages: 885 - 892
Method of Biopsy and Incidence of Positive Margins in Primary Melanoma Virginia H. StellH. James NortonRichard L. White Jr. OriginalPaper 21 November 2006 Pages: 893 - 898
The Reproducibility in Routine Clinical Practice of Sentinel Lymph Node Identification by Pre-operative Lymphoscintigraphy in Patients with Cutaneous Melanoma Roger F. UrenRobert Howman-GilesJohn F. Thompson OriginalPaper 11 November 2006 Pages: 899 - 905
Histological Features of Melanoma Sentinel Lymph Node Metastases Associated with Status of the Completion Lymphadenectomy and Rate of Subsequent Relapse Anand GovindarajanDanny M. GhazarianWey L. Leong OriginalPaper 29 November 2006 Pages: 906 - 912
Lymphoseek: A Molecular Imaging Agent for Melanoma Sentinel Lymph Node Mapping Anne M. WallaceCarl K. HohDavid R. Vera OriginalPaper 05 December 2006 Pages: 913 - 921
Impact of Surgical Palliation on Quality of Life in Patients with Advanced Malignancy: Results of the Decisions and Outcomes in Palliative Surgery (DOPS) Trial Yale D. PodnosGloria JuarezLawrence D. Wagman OriginalPaper 16 November 2006 Pages: 922 - 928
A Systematic Review of Deep Venous Thrombosis Prophylaxis in Cancer Patients: Implications for Improving Quality Michael J. LeonardiMarcia L. McGoryClifford Y. Ko ContinuingEducation 10 November 2006 Pages: 929 - 936
A Modified Internal Jugular Vein Access for Long-Term Catheter Placement in Cancer Patients Marcos Pires e Albuquerque OriginalPaper 11 November 2006 Pages: 937 - 941
Small Molecule Tyrosine Kinase Inhibitors in the Treatment of Solid Tumors: An Update of Recent Developments Neeltje SteeghsJohan W. R. NortierHans Gelderblom OriginalPaper 14 November 2006 Pages: 942 - 953
Reduced Incidence of Nodal Micrometastasis after Major Response to Neoadjuvant Chemoradiation in Locally Advanced Esophageal Cancer Klaus L. PrenzelAlexandra KönigArnulf H. Hölscher OriginalPaper 11 November 2006 Pages: 954 - 959
Expression of Carbohydrate Antigens in Human Esophageal Squamous Cell Carcinoma: Prognostic Application and Its Diagnostic Implications Ahmad FariedHitoshi KimuraHiroyuki Kuwano OriginalPaper 09 November 2006 Pages: 960 - 967
Incidence and Treatment of Tracheal Cancer: A Nationwide Study in The Netherlands Jimmie HoningsJos A. A. M. van DijckHenri A. M. Marres OriginalPaper 02 December 2006 Pages: 968 - 976
Molecular Prognostic Factors in Adenocarcinoma of the Esophagus and Gastroesophageal Junction S. M. LagardeF. J. W. ten KateJ. J. B. van Lanschot Review 24 November 2006 Pages: 977 - 991
Prognostic Factors for Pulmonary Metastasectomy in Hepatocellular Carcinoma Shuenn-Wen KuoYih-Leong ChangYung-Chie Lee OriginalPaper 06 December 2006 Pages: 992 - 997
Prognosis Scores of Tokuhashi and Tomita for Patients With Spinal Metastases of Renal Cancer Benjamin UlmarUlrike NaumannKlaus Huch OriginalPaper 03 November 2006 Pages: 998 - 1004